Marine Drugs (Nov 2012)

Synthesis and Antitumor Activities of Derivatives of the Marine Mangrove Fungal Metabolite Deoxybostrycin

  • Zhi-Gang She,
  • Yuhua Long,
  • Yong-Cheng Lin,
  • Sheng-Ping Chen,
  • Jue-Heng Wu,
  • Bing Yang,
  • Jia Li,
  • Li-Li Zhong,
  • Hong Chen,
  • Xun Zhu

DOI
https://doi.org/10.3390/md10122715
Journal volume & issue
Vol. 10, no. 12
pp. 2715 – 2728

Abstract

Read online

Deoxybostrycin (1) is an anthraquinone compound derived from the marine mangrove fungus Nigrospora sp. No. 1403 and has potential to be a lead for new drugs because of its various biological properties. A series of new derivatives (2–22) of deoxybostrycin were synthesized. The in vitro cytotoxicity of all the new compounds was tested against MDA-MB-435, HepG2 and HCT-116 cancer cell lines. Most of the compounds exhibit strong cytotoxicity with IC50 values ranging from 0.62 to 10 μM. Compounds 19, 21 display comparable cytotoxicity against MDA-MB-435 to epirubicin, the positive control. The primary screening results indicate that the deoxybostrycin derivatives might be a valuable source of new potent anticancer drug candidates.

Keywords